Загрузка страницы

An ABC to manage cardiogenic shock - EuroPCR 2017

Beginning with management - even before the patient arrives at the hospital - S. B. King III, A. Elghamaz and S. Brugaletta share with you their clinical expertise. From the key elements in a patient’s history, to learning why the choice of a team is critical, each step is explained and commented. What differentiates this patient from one presenting with STEMI? What will you need to stabilize the patient? What tools, devices or pharmacologic products should be employed? Why is opening the artery critical? What do you do when your patient remains unstable or how do you provide haemodynamic support? Learn more here…

This interview was filmed at EuroPCR 2017: see more videos here: https://www.pcronline.com/Cases-resou...

Видео An ABC to manage cardiogenic shock - EuroPCR 2017 канала PCR
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
30 мая 2017 г. 13:34:02
00:07:41
Другие видео канала
Seeing is believing: Predictable and durable treatment of mitral regurgitation across etiologiesSeeing is believing: Predictable and durable treatment of mitral regurgitation across etiologiesSnapshot of EuroPCR 2017 Day 3Snapshot of EuroPCR 2017 Day 3State-of-the-art imaging for structural heart disease interventions - EuroPCR 2022State-of-the-art imaging for structural heart disease interventions - EuroPCR 2022Sirolimus-coated balloon: expanding scope of indications for complex CAD treatment - EuroPCR 2024Sirolimus-coated balloon: expanding scope of indications for complex CAD treatment - EuroPCR 2024EuroPCR 2023 Industry Partner Interview: Edwards LifesciencesEuroPCR 2023 Industry Partner Interview: Edwards LifesciencesPCR Select from #EuroPCR 2023 - Day 3PCR Select from #EuroPCR 2023 - Day 3PORTICO I Study: 30-day outcomes - EuroPCR 2018PORTICO I Study: 30-day outcomes - EuroPCR 2018QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlabQFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlabIt was an eventful week at EuroPCR 2018!It was an eventful week at EuroPCR 2018!Integrating FFRangio into your daily practice - Empowering wire-free insights - EuroPCR 2023Integrating FFRangio into your daily practice - Empowering wire-free insights - EuroPCR 2023PCR's Got Talent Best Abstract Winner -  EuroPCR 2017PCR's Got Talent Best Abstract Winner - EuroPCR 2017Modern management of PCI in complex lesions - EuroPCR 2023Modern management of PCI in complex lesions - EuroPCR 2023Ultra-thin strut stenting to manage challenges in STEMI - EuroPCR 2023Ultra-thin strut stenting to manage challenges in STEMI - EuroPCR 2023Image-based FFR during coronary catheterisationImage-based FFR during coronary catheterisationTriluminate trial: deep dive into the outcomes #ACC23 #WCCardioTriluminate trial: deep dive into the outcomes #ACC23 #WCCardioDefining together the ideal TAVI platform of the future - EuroPCR 2023Defining together the ideal TAVI platform of the future - EuroPCR 2023A comprehensive portfolio to treat tricuspid regurgitation - PCR London Valves 2022A comprehensive portfolio to treat tricuspid regurgitation - PCR London Valves 2022Simplifying complex coronary interventions by adopting angiography-based physiology - EuroPCR 2022Simplifying complex coronary interventions by adopting angiography-based physiology - EuroPCR 2022Use of 4D ICE in tricuspid and mitral valve interventions - EuroPCR 2023Use of 4D ICE in tricuspid and mitral valve interventions - EuroPCR 2023Tricuspid Regurgitation (TR) management with the Cardioband Tricuspid System: PCR London valves 2019Tricuspid Regurgitation (TR) management with the Cardioband Tricuspid System: PCR London valves 2019BRS: experience, unresolved issues and the outlook for the next-generationBRS: experience, unresolved issues and the outlook for the next-generation
Яндекс.Метрика